dihydroaremisinin (DHA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dihydroaremisinin (DHA), covering 2018-01-18 to 2018-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC [Phase 2]